An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on Reddit asked whether ghrp-6 could help them eat more while they're taking Vyvanse, a prescription stimulant that suppresses appetite and makes it hard for them to gain weight. They’re naturally thin and worried about trying something new. The post is basically a person looking for a practical fix to feel hungrier so they can eat enough while using a medication they need for school. GHRP‑6 is a short synthetic peptide. In plain terms, it’s a lab-made fragment that nudges the body’s systems in a way similar to a natural hormone. Specifically, GHRP‑6 stimulates the release of growth hormone and can also increase levels of a hunger-promoting hormone called ghrelin (ghrelin is the “I’m hungry” signal your body makes). People sometimes try it because it’s been reported to boost appetite and promote weight gain in animals and a few small human reports, but it’s not an approved appetite drug you’d get through normal medical channels. What the existing research and reports actually show is limited. Most reliable studies are small, short, or done in animals. There are some lab and animal studies showing GHRP‑6 raises ghrelin and can increase food intake. Human evidence is scarce and often comes from tiny trials or anecdotal reports — not the kind of large, well-controlled studies doctors rely on to say something is safe and effective. Nobody has shown, in robust clinical trials, that GHRP‑6 reliably fixes stimulant-induced appetite loss in people taking medications like Vyvanse. Why this matters: if Vyvanse suppresses your appetite and that’s causing weight loss or trouble eating, a safe, effective solution would be valuable. People who are underweight, have trouble concentrating when hungry, or are concerned about long-term health effects of poor nutrition are the most interested. However, asking about GHRP‑6 is essentially asking about an experimental workaround — it’s not a standard, well-validated treatment for stimulant-related appetite loss. Important caveats and risks: GHRP‑6 isn’t approved by major drug regulators as an appetite treatment, so quality and dosing are uncertain if obtained outside clinical research. Short-term effects can include increased hunger, water retention, or changes in blood sugar; long-term effects aren’t well-studied. There’s also potential for interactions with other drugs or underlying conditions. People with hormone-sensitive cancers, diabetes, or heart problems should be especially cautious. The safest path is to raise this with your prescribing doctor: they can check for medical causes, consider adjusting medication timing or dose, suggest proven strategies (nutrient-dense meals, scheduled snacks, appetite-stimulating foods), or, if appropriate, consider approved alternatives. Bottom line: GHRP‑6 might sound promising because it can boost hunger in lab settings, but evidence in people is weak and safety is uncertain — talk to your doctor before trying experimental peptides.
Source: r/Peptides